+86-571-85081802     info@multin.cn
Factory Supply High Quality 99% Raw Material Meloxicam Powder CAS 71125-38-7
Home » Products » Pharmaceutical Intermediate » Factory Supply High Quality 99% Raw Material Meloxicam Powder CAS 71125-38-7

Product Category

Contact Us

 Tel: +86-571-85081802
  Phone: +86-13655719091
 E-mail: info@multin.cn
  Add: Room 321,lingjun Mansion South,the 10th Chaowang Road,xiacheng District,hangzhou City,zhejiang Province China

Factory Supply High Quality 99% Raw Material Meloxicam Powder CAS 71125-38-7 Factory Supply High Quality 99% Raw Material Meloxicam Powder CAS 71125-38-7
Factory Supply High Quality 99% Raw Material Meloxicam Powder CAS 71125-38-7 Factory Supply High Quality 99% Raw Material Meloxicam Powder CAS 71125-38-7
Factory Supply High Quality 99% Raw Material Meloxicam Powder CAS 71125-38-7 Factory Supply High Quality 99% Raw Material Meloxicam Powder CAS 71125-38-7

loading

Factory Supply High Quality 99% Raw Material Meloxicam Powder CAS 71125-38-7

Share to:
sharethis sharing button
Product name: Meloxicam
Synonyms: metacam; mobic
MOQ: 1kg
CAS No.:71125-38-7
Appearance: Yellow powder
Molecular Formula: C14H13N3O4S2
Molecular Weight: 351.40
Assay: 98.0%~102.0%
Application: Pharma grade
Packing: As per your request
Storage: Preserve in tight,light-resistant containers in a cool place
  • CAS 71125-38-7

  • MT

  • 2921420090

  • 71125-38-7

Availability:

High-purity-Furazolidone


Top Quality Meloxicam For Arthritis Anti-inflammatory CAS 71125-38-7

Product name:  Meloxicam
Synonyms: metacam; mobic
 MOQ: 1kg
 CAS No.:71125-38-7
 Appearance: Yellow powder
 Molecular Formula: C14H13N3O4S2
 Molecular Weight: 351.40
 Assay: 98.0%~102.0%
 Application: Pharma grade 
 Packing: As per your request

Storage: Preserve in tight,light-resistant containers in a cool place

Function:
 
Older patients and patients with an increased risk of adverse reactions;
In elderly patients, patients with rheumatoid arthritis and ankylosing spondylitis treatment recommended dose for 7.5mg/days. Starting dose in patients with increased risk of adverse reactions to 7.5mg/days.
Patients with renal insufficiency:
Patients with severe renal failure and need dialysis, the dose should not exceed 7.5mg/days.
Patients with mild to moderate renal insufficiency do not need to adjust the dosage (such as patients with creatinine clearance greater than 25ml/minutes).
Patients with severe renal failure without dialysis, see [taboo].
Patients with hepatic insufficiency: In patients with mild and moderate hepatic insufficiency no need to adjust the dose. In patients with severe hepatic insufficiency, see [taboo].
Children: This product is not for use in children under 15 years of age. Meloxicam has other forms, may apply.



 



1




Packing and Shipping:

packing

packing1


Previous: 
Next: 

OUR PRODUCTS

HOT LINKS

Copyright  2020 ZHEJIANG MULTINPHARMA CO.,LTD All Rights Reserved  浙ICP备17013806号-1  |  Technology by www.leadong.com